A phase II study to evaluate the safety and efficacy of OQL011 on VEGFR inhibitor-associated hand-foot-skin reaction in cancer patients Meeting Abstract
| Authors: | Lacouture, M. E.; Anadkat, M. J.; Marathe, O. S.; Vogelzang, N. J.; Lam, E. T.; Kaffenberger, B.; Choi, J. N.; Webb, M. L.; Tyler, R. C.; Ju, J. G.; Tang, H.; Luo, J.; Patel, A. |
| Abstract Title: | A phase II study to evaluate the safety and efficacy of OQL011 on VEGFR inhibitor-associated hand-foot-skin reaction in cancer patients |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120306175 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.TPS12132 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS12132 -- Source: Wos |
